Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
10x Genomics, Inc. (TXG) Stock Analysis: Exploring a 12% Potential Upside Amidst Healthcare Innovation 19 August 2025
Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Growth Potential Amidst CNS Drug Innovations 19 August 2025
Novavax, Inc. (NVAX) Stock Analysis: Exploring a 35% Potential Upside Amid Biotech Challenges 19 August 2025
Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 37.71% Potential Upside 19 August 2025
MannKind Corporation (MNKD) Investor Outlook: Unpacking a 142.78% Potential Upside with Promising Biotech Innovations 19 August 2025
Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a 116% Potential Upside 19 August 2025
ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 19.5% Upside Potential in the Biotech Sector 19 August 2025
NewAmsterdam Pharma Company N.V. (NAMS): Investor Outlook on a Promising 58.77% Upside Potential 19 August 2025
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth Challenges with a 8.48% Potential Upside 19 August 2025
Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating a 16.8% Revenue Growth in a Competitive Healthcare Sector 19 August 2025
Acadia Healthcare (ACHC) Stock Analysis: Evaluating a 44% Potential Upside Amidst Market Volatility 19 August 2025
Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Eyeing a 109% Potential Upside in the Biotech Arena 19 August 2025
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 173.81% Upside Potential Captures Investor Interest 19 August 2025
Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unlocking a 189% Potential Upside 19 August 2025
Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Analyzing the 138.81% Upside Potential 19 August 2025
Mesoblast Limited (MESO) Stock Analysis: A 69% Potential Upside Amidst Biotech Challenges 19 August 2025
Clover Health Investments (CLOV): A 39.85% Potential Upside Amidst Healthcare Sector Growth 19 August 2025
Astrana Health Inc. (ASTH) Stock Analysis: A Promising 46.59% Potential Upside to Entice Investors 19 August 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
Aston Martin reports lower Q3 volumes but expects stronger Q4 driven by Valhalla deliveries 29 October 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
